Full-Time

Jr. Clinical Trials Data Specialist

Posted on 1/1/2025

Tempus

Tempus

1,001-5,000 employees

AI-driven healthcare data analysis platform

AI & Machine Learning
Biotechnology
Healthcare

Compensation Overview

$46k - $50kAnnually

+ Incentive Compensation + Restricted Stock Units

Entry, Junior

Remote in USA

Category
Healthcare Administration & Support
Nursing & Allied Health Professionals
Medical, Clinical & Veterinary
Required Skills
Data Analysis
Requirements
  • Minimum of a BS degree in Genetics, Molecular Genetics, Cancer Biology, or Biological Sciences.
  • Willingness to be flexible.
  • Ability to learn new skills quickly and adapt to new processes smoothly.
  • Excellent communication skills with the ability to work both independently and in a group setting.
  • Excitement and drive to make a difference in a fast-paced energetic work environment.
Responsibilities
  • Works collaboratively within cross-functional teams at Tempus (including but not limited to scientists, pathologists, product development, etc.) to create customized clinical reports.
  • Analyze patient clinical records and molecular testing results to identify potential clinical trials.
  • Perform critical quality control functions in clinical report workflow.
  • Support ongoing and future projects within the team.
  • Ability to quickly adjust priorities according to workflow or business needs.
Desired Qualifications
  • Hematology/oncology knowledge.
  • Experience reading and critically evaluating clinical trials.

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in the healthcare sector. The company offers a platform that analyzes medical data, helping physicians make better treatment decisions by providing insights from medical images and identifying care gaps. For pharmaceutical and biotech companies, Tempus aids in drug development by discovering new targets and assessing treatment effectiveness. Patients benefit from personalized therapy options identified through the platform. Tempus conducts significant research, particularly in cancer, and has developed tools like a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. The company generates revenue by charging healthcare providers and companies for access to its platform and insights, aiming to improve patient care and support drug development.

Company Stage

IPO

Total Funding

$894.9M

Headquarters

Chicago, Illinois

Founded

2015

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

1%
Simplify Jobs

Simplify's Take

What believers are saying

  • Increased adoption of AI tools aligns with Tempus' precision medicine focus.
  • Integration of genomic data with EMRs expands Tempus' platform reach.
  • Growing emphasis on RNA-based biomarkers benefits Tempus' recent Genialis partnership.

What critics are saying

  • Competition from partners like Genialis may lead to conflicts of interest.
  • Ambry Genetics acquisition could pose financial risks if synergies aren't realized.
  • Integration with Flatiron Health may face technical challenges or unmet clinical benefits.

What makes Tempus unique

  • Tempus uses AI to analyze clinical and molecular data for precision medicine.
  • Their platform offers personalized therapy options, especially in cancer treatment.
  • Tempus collaborates with pharmaceutical companies to enhance drug development processes.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Relocation Assistance

Company Equity

Performance Bonus

INACTIVE